Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDizziness is a recognised side effect of tirzepatide. Clinical trial data show it affects a meaningful minority of people, typically in the early weeks of treatment or after a dose increase, and it usually settles. If you're feeling dizzy on Mounjaro right now, you're not imagining it — and in most cases it has a straightforward explanation. These are prescription-only medicines, so a prescriber is the right person to assess whether what you're experiencing is expected or needs attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine and involving 2,539 adults with obesity, systematically tracked adverse events across the full 72-week programme. Dizziness appeared in the reported side-effect data for tirzepatide at all doses tested, it was more common than many people expect but, crucially, it was rarely severe enough to cause participants to stop treatment. The NHS tirzepatide medicines page lists dizziness among the common side effects, meaning it occurs in roughly one in ten people or more. That figure is worth holding onto: common does not mean dangerous, and it does not mean you simply have to put up with it either.
Understanding the mechanism matters here, because the cause shapes the remedy. Tirzepatide works partly by slowing gastric emptying and reducing appetite. Eat less, drink less, and your blood volume drops a little. That small drop in circulating fluid can cause blood pressure to fall momentarily when you stand up or move quickly, producing the light-headed, slightly unsteady sensation most people describe when they talk about feeling dizzy on Mounjaro. It is a physiological response, not a sign the medicine is failing or harming you.
If you want a fuller picture of the general side-effect profile before your next prescriber conversation, the broader guide to feeling ill on Mounjaro covers nausea, fatigue and related symptoms alongside dizziness.
Timing is the clearest clue. The pattern most prescribers see is dizziness peaking in the first week or two after starting 2.5 mg, then settling, then reappearing briefly when the dose goes up, and settling again. This corresponds exactly to the periods when the medicine is having its strongest early effect on appetite suppression and fluid intake before the body adjusts.
Three physiological threads typically converge at these moments. First, a fall in calorie and carbohydrate intake can reduce blood glucose slightly, especially in people whose blood sugar was running high before treatment. Second, if nausea is keeping fluid intake low, mild dehydration makes postural dizziness more likely. Third, the medicine's effect on gastric emptying alters how quickly glucose reaches the bloodstream, which can produce small fluctuations that some people notice as light-headedness after eating.
People taking medicines for type 2 diabetes alongside tirzepatide need particular attention here, because the combined glucose-lowering effect can occasionally push levels low enough to cause genuine hypoglycaemia. That is a separate situation from the postural dizziness described above, and a prescriber needs to know about it. The detailed explanation of why dizziness happens on Mounjaro explores these threads individually.
The evidence base for managing this symptom is largely practical rather than pharmacological. Getting enough fluid is the single most useful thing. Most adults need considerably more water during the early weeks of tirzepatide than they feel thirsty for, precisely because reduced appetite tends to carry reduced thirst with it. Sipping consistently through the day, rather than trying to catch up in the evening, makes a measurable difference for many people.
Moving slowly from sitting to standing gives your cardiovascular system time to redistribute blood. It sounds obvious, but it is easy to forget when you feel fine sitting down. Eating small amounts regularly, rather than skipping meals because appetite is low, keeps blood sugar steadier. Salt intake, within sensible limits, supports blood pressure in people whose diet has become quite restrictive.
Timing your injection relative to your most active parts of the day is worth discussing with your prescriber. Some people find injecting in the evening means the first 24 to 48 hours of peak side effects coincide with rest, not a commute. For context on how much treatment costs and what a private prescription includes, the Mounjaro cost page sets out what a complete service covers. And if you notice other physical changes alongside the dizziness, the guide to feeling cold on Mounjaro is worth a read, as both symptoms can share the same underlying cause in some people.
Most dizziness on tirzepatide is mild and passes. Some presentations need prompt assessment. Get same-day medical help if dizziness is severe, arrives suddenly with no obvious postural trigger, is accompanied by chest pain or palpitations, or does not improve after sitting down and drinking water. The MHRA's Yellow Card scheme is how patients and healthcare professionals report unexpected or serious side effects, if what you're experiencing feels out of proportion to what you read here, reporting it contributes to the ongoing safety monitoring of these medicines.
Fainting is different from dizziness and always warrants a clinical review. So does dizziness that is getting worse rather than better as the weeks pass, or that is affecting your ability to drive or work. A prescriber may assess whether your dose pace needs adjusting, whether dehydration is a factor, or whether another medicine you take is interacting with the effect. You can read more about a specific concern (interaction with certain analgesics, for instance) on the page covering Mounjaro and co-codamol. Our clinical team is available seven days a week for aftercare queries, which is where a question like this belongs. If you haven't started treatment yet and want to understand whether Mounjaro is suitable for you, starting a free consultation is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.